{"title":"Holmesâ€™ projected prison release date moved up for expected good behavior","link":"https://arstechnica.com/?p=1953295","date":1689185864000,"content":"<div>\n<figure>\n  <img src=\"https://cdn.arstechnica.net/wp-content/uploads/2023/07/GettyImages-1258295915-800x583.jpeg\" alt=\"Elizabeth Holmes, founder of Theranos Inc., left, arrives at Federal Prison Camp Bryan in Bryan, Texas, US, on Tuesday, May 30, 2023. \" />\n      <p><a href=\"https://cdn.arstechnica.net/wp-content/uploads/2023/07/GettyImages-1258295915-scaled.jpeg\">Enlarge</a> <span>/</span> Elizabeth Holmes, founder of Theranos Inc., left, arrives at Federal Prison Camp Bryan in Bryan, Texas, US, on Tuesday, May 30, 2023.  (credit: <a href=\"https://www.gettyimages.com/detail/news-photo/elizabeth-holmes-founder-of-theranos-inc-left-arrives-at-news-photo/1258295915?adppopup=true\">Getty | Sergio Flores</a>)</p>  </figure>\n\n\n\n\n\n\n<div><a name=\"page-1\"></a></div>\n<p>Just six weeks into her 11-year, three-month prison sentence, disgraced biotech entrepreneur Elizabeth Holmes has apparently already behaved well enough to convince the US Bureau of Prisons that she'll likely get out early.</p>\n<p><a href=\"https://www.bop.gov/mobile/find_inmate/byname.jsp\">Federal prison records</a> now show that Holmes' projected release date is December 29, 2032. That puts her total stay at the <a href=\"https://arstechnica.com/science/2023/05/elizabeth-holmes-has-reported-to-prison-in-texas-to-start-her-11-year-sentence/\">minimum-security women's prison camp in Bryan, Texas</a>, at just 115 months, or a little over 9.5 years.</p>\n<p>Last November, US District Judge Edward Davila <a href=\"https://arstechnica.com/science/2022/11/elizabeth-holmes-sentenced-to-11-25-years-in-prison-for-theranos-fraud/\">sentenced Holmes to 135 months in federal prison</a> for four counts of defrauding investors of her infamous and now defunct blood testing start-up, Theranos. Holmes, along with her ex-boyfriend and former Theranos President, Ramesh \"Sunny\" Balwani, claimed their proprietary technology could perform hundreds of medical tests using just a drop of blood from a finger prick. While their claims and publicity helped drive the company's valuation up to $9 billion in 2014, the technology never actually worked.</p></div><p><a href=\"https://arstechnica.com/?p=1953295#p3\">Read 6 remaining paragraphs</a> | <a href=\"https://arstechnica.com/?p=1953295&amp;comments=1\">Comments</a></p>","author":"Beth Mole","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"b95e6f844b2bb0563d1506d88908873111d64aa9433f4fc90e036b668710666d","category":"Tech"}